Market LIVE
Published markets; coverage varies by country
Product profile · United States

HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45%

 ·  Patent Litigation & Settlement History ↓

IngredientHEPARIN SODIUM
Application typeNDA
Application017029
Product025
Dosage formINJECTABLE
RouteINJECTION
Strength100 UNITS/ML
Approval date2017-08-24
Marketing statusPrescription
Status event—
ApplicantFRESENIUS KABI USA
Product source

Current GenericRadar decision

Year2017
SelectionDEEP_REVIEW
ReviewFINAL
Anchor typeAPPROVAL_YEAR_FALLBACK
Anchor date2017-08-24
Patent anchor—
Exclusivity anchor—
Protection date—
First Final ANDA—
Status event—

Available evidence does not establish a full-scope DS/DS-equivalent or full-coverage exclusivity anchor; approval-year DEEP_REVIEW is proposed. Direct Final-ANDA linkage may change the result.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
No patent facts are recorded for this product.

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
No exclusivity facts are recorded in this product snapshot.

2026-10-10 · CURRENT_SNAPSHOT_NO_RECORD · Historical coverage: NOT_COMPLETE

2026-10-10 · NO_RECORD_IN_CURRENT_SNAPSHOT · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
087905 / 001FINAL_APPROVAL · FINAL_APPROVED1983-04-20—SOLOPAK MEDICAL PRODUCTS INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
087906 / 001FINAL_APPROVAL · FINAL_APPROVED1983-04-20—SMITH AND NEPHEW SOLOPAK DIV SMITH AND NEPHEWNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
087959 / 001FINAL_APPROVAL · FINAL_APPROVED1983-04-20—SMITH AND NEPHEW SOLOPAK DIV SMITH AND NEPHEWNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
088459 / 001FINAL_APPROVAL · FINAL_APPROVED1984-07-26—SOLOPAK MEDICAL PRODUCTS INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
088460 / 001FINAL_APPROVAL · FINAL_APPROVED1984-07-26—SMITH AND NEPHEW SOLOPAK DIV SMITH AND NEPHEWNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
088581 / 001FINAL_APPROVAL · FINAL_APPROVED1984-10-25—SMITH AND NEPHEW SOLOPAK DIV SMITH AND NEPHEWNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
089064 / 001FINAL_APPROVAL · FINAL_APPROVED1985-10-09—LUITPOLD PHARMACEUTICALS INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 7 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
087905 / 001SOLOPAK MEDICAL PRODUCTS INCFINAL_APPROVAL · FINAL_APPROVED1983-04-20 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
087906 / 001SMITH AND NEPHEW SOLOPAK DIV SMITH AND NEPHEWFINAL_APPROVAL · FINAL_APPROVED1983-04-20 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
087959 / 001SMITH AND NEPHEW SOLOPAK DIV SMITH AND NEPHEWFINAL_APPROVAL · FINAL_APPROVED1983-04-20 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
088459 / 001SOLOPAK MEDICAL PRODUCTS INCFINAL_APPROVAL · FINAL_APPROVED1984-07-26 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
088460 / 001SMITH AND NEPHEW SOLOPAK DIV SMITH AND NEPHEWFINAL_APPROVAL · FINAL_APPROVED1984-07-26 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
088581 / 001SMITH AND NEPHEW SOLOPAK DIV SMITH AND NEPHEWFINAL_APPROVAL · FINAL_APPROVED1984-10-25 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
089064 / 001LUITPOLD PHARMACEUTICALS INCFINAL_APPROVAL · FINAL_APPROVED1985-10-09 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.